ACTONEL 35 mg, gastro-resistant tablet 4 tablets
Active ingredients: Risedronic acid, Risedronate sodium hemi-pentahydrate
Commercialized according to BDPMDispensing in France: Prescription only
Gastro-resistant tablet4 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ACTONEL 35 mg, comprimé gastro-résistant
- Pharmaceutical form
- comprimé gastro-résistant(e)
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC aluminium de 4 comprimé(s)
- Marketing authorisation holder
- THERAMEX IRELAND (IRLANDE)
- Reimbursement according to BDPM
- 65%
- Reimbursement conditions
- Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Ostéoporose post-ménopausique (fragilité osseuse par perte de calcium par les os apparaissant chez les femmes après la ménopause) pour réduire le risque de fractures vertébrales et de hanche chez les patientes à fort risque de fracture. ; JOURNAL OFFICIEL ; 15/02/18
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 15 Feb 2018
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64392560CIP73008415CIP133400930084151Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| RISÉDRONATE MONOSODIQUEcomprimé | 35 mg · un comprimé | SA |
| ACIDE RISÉDRONIQUEcomprimé | 32,50 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.